Is It Time to Shift the Monotherapy After Percutaneous Coronary Intervention From Aspirin to P2Y12 Inhibitors? ― New Normal in the New-Generation Era ― | Zendy

AI Assistant Blog Pricing

Is It Time to Shift the Monotherapy After Percutaneous Coronary Intervention From Aspirin to P2Y<sub>12</sub> Inhibitors? ― New Normal in the New-Generation Era ―

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.